Monoferric Dosing Frequency
Monoferric is administered as a single intravenous dose and can be repeated only when iron deficiency anemia recurs—there is no fixed redosing interval. 1
Dosing Schedule
Initial Dose
- For patients ≥50 kg: Administer 1,000 mg as a single IV infusion over at least 20 minutes 1
- For patients <50 kg: Administer 20 mg/kg actual body weight as a single IV infusion over at least 20 minutes 1
Repeat Dosing
- Repeat the dose only if iron deficiency anemia reoccurs 1
- The FDA label does not specify a minimum time interval between doses 1
- Monitor hemoglobin and iron parameters (serum ferritin and transferrin saturation) to determine when redosing is needed 1
Monitoring Parameters
When to Consider Redosing
- Monitor hematologic response (hemoglobin and hematocrit) after initial administration 1
- Monitor iron parameters including serum ferritin and transferrin saturation 1
- Serum ferritin peaks approximately 7 days after Monoferric administration and returns to stable levels after about 4 weeks 1
- Redose when clinical and laboratory evidence indicates recurrent iron deficiency anemia 1
Context Within IV Iron Formulations
Monoferric is designed as a high-dose, single-infusion product, which aligns with current guideline preferences for IV iron formulations that can replace iron deficits with 1-2 infusions rather than multiple smaller doses 2. This contrasts with older formulations like iron sucrose (requiring 3-5 doses) or ferric gluconate (requiring 8 doses given no closer than every other day) 2.
Critical Safety Considerations
- Only administer when personnel and therapies are immediately available for serious hypersensitivity reactions 1
- Monitor patients for signs of hypersensitivity during and for at least 30 minutes after infusion completion 1
- Serious hypersensitivity reactions occurred in 0.3% of patients in clinical trials 1
- Do not administer to patients with iron overload, as excessive parenteral iron can lead to hemosiderosis or hemochromatosis 1
Common Pitfall to Avoid
Do not establish a routine redosing schedule (e.g., every 3 months or every 6 months) without documented recurrence of iron deficiency anemia 1. The label explicitly states to repeat dosing only when IDA reoccurs, not on a predetermined timeline. Unnecessary repeat dosing increases the risk of iron overload 1.